Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01489995 · ClinicalTrials.gov registry record · Phase 1
Migalastat Food Effect Study
A Phase 1 study, sponsored by Amicus Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01489995 is a Phase 1 study that has completed, run by Amicus Therapeutics. The registered enrollment target is 20 participants.
The verdict
NCT01489995, a Phase 1 study, has completed, sponsored by Amicus Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
A 5-period crossover study to evaluate the effect of meal type and timing on migalastat HCl pharmacokinetics in healthy male and female subjects. Subjects will be randomly assigned to 1 of 5 treatment sequences and will receive each treatment over the course of 5 weekly periods.
Interventions
- DRUG A (migalastat)
- DRUG B (migalastat)
- DRUG C (migalastat)
- DRUG D (migalastat)
- DRUG E (migalastat)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-10 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01489995
The ClinicalTrials.gov registry entry for NCT01489995 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amicus Therapeutics, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which A (migalastat) is the first listed.
NCT01489995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01489995 about?
NCT01489995 is a clinical study titled "Migalastat Food Effect Study". A 5-period crossover study to evaluate the effect of meal type and timing on migalastat HCl pharmacokinetics in healthy male and female subjects. Subjects will be randomly assigned to 1 of 5 treatment sequences and will receive each treatment over the course of 5 weekly periods.
What is the current status of trial NCT01489995?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01489995?
The interventions under investigation include: A (migalastat) (DRUG), B (migalastat) (DRUG), C (migalastat) (DRUG), D (migalastat) (DRUG), E (migalastat) (DRUG).
Who is sponsoring clinical trial NCT01489995?
This trial is sponsored by Amicus Therapeutics, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.